A detailed history of Driehaus Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Driehaus Capital Management LLC holds 842 shares of LLY stock, worth $770,067. This represents 0.01% of its overall portfolio holdings.

Number of Shares
842
Previous 604 39.4%
Holding current value
$770,067
Previous $352,000 86.08%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $140,943 - $188,562
238 Added 39.4%
842 $655,000
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $399,054 - $550,157
-918 Reduced 60.32%
604 $324,000
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $533,826 - $713,787
1,522 New
1,522 $713,000
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $308,553 - $354,122
-4,076 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $302,479 - $357,057
4,076 New
4,076 $315,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.